256 related articles for article (PubMed ID: 14555707)
1. Sulindac metabolites induce caspase- and proteasome-dependent degradation of beta-catenin protein in human colon cancer cells.
Rice PL; Kelloff J; Sullivan H; Driggers LJ; Beard KS; Kuwada S; Piazza G; Ahnen DJ
Mol Cancer Ther; 2003 Sep; 2(9):885-92. PubMed ID: 14555707
[TBL] [Abstract][Full Text] [Related]
2. Pro-apoptotic actions of exisulind and CP461 in SW480 colon tumor cells involve beta-catenin and cyclin D1 down-regulation.
Li H; Liu L; David ML; Whitehead CM; Chen M; Fetter JR; Sperl GJ; Pamukcu R; Thompson WJ
Biochem Pharmacol; 2002 Nov; 64(9):1325-36. PubMed ID: 12392815
[TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis by the proteasome inhibitor MG132 in human HCC cells: Possible correlation with specific caspase-dependent cleavage of beta-catenin and inhibition of beta-catenin-mediated transactivation.
Cervello M; Giannitrapani L; La Rosa M; Notarbartolo M; Labbozzetta M; Poma P; Montalto G; D'Alessandro N
Int J Mol Med; 2004 May; 13(5):741-8. PubMed ID: 15067380
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites.
Rice PL; Goldberg RJ; Ray EC; Driggers LJ; Ahnen DJ
Cancer Res; 2001 Feb; 61(4):1541-7. PubMed ID: 11245463
[TBL] [Abstract][Full Text] [Related]
5. Sulindac sulfone is most effective in modulating beta-catenin-mediated transcription in cells with mutant APC.
Chang WC; Everley LC; Pfeiffer GR; Cooper HS; Barusevicius A; Clapper ML
Ann N Y Acad Sci; 2005 Nov; 1059():41-55. PubMed ID: 16382042
[TBL] [Abstract][Full Text] [Related]
6. Sulindac targets nuclear beta-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines.
Boon EM; Keller JJ; Wormhoudt TA; Giardiello FM; Offerhaus GJ; van der Neut R; Pals ST
Br J Cancer; 2004 Jan; 90(1):224-9. PubMed ID: 14710233
[TBL] [Abstract][Full Text] [Related]
7. Regulation of beta-catenin signaling by the B56 subunit of protein phosphatase 2A.
Seeling JM; Miller JR; Gil R; Moon RT; White R; Virshup DM
Science; 1999 Mar; 283(5410):2089-91. PubMed ID: 10092233
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of proteasome function induced apoptosis in gastric cancer.
Fan XM; Wong BC; Wang WP; Zhou XM; Cho CH; Yuen ST; Leung SY; Lin MC; Kung HF; Lam SK
Int J Cancer; 2001 Aug; 93(4):481-8. PubMed ID: 11477551
[TBL] [Abstract][Full Text] [Related]
9. Sulindac sulfide inhibits epidermal growth factor-induced phosphorylation of extracellular-regulated kinase 1/2 and Bad in human colon cancer cells.
Rice PL; Washington M; Schleman S; Beard KS; Driggers LJ; Ahnen DJ
Cancer Res; 2003 Feb; 63(3):616-20. PubMed ID: 12566304
[TBL] [Abstract][Full Text] [Related]
10. The ubiquitin-proteasome pathway and serine kinase activity modulate adenomatous polyposis coli protein-mediated regulation of beta-catenin-lymphocyte enhancer-binding factor signaling.
Easwaran V; Song V; Polakis P; Byers S
J Biol Chem; 1999 Jun; 274(23):16641-5. PubMed ID: 10347231
[TBL] [Abstract][Full Text] [Related]
11. Sulindac independently modulates extracellular signal-regulated kinase 1/2 and cyclic GMP-dependent protein kinase signaling pathways.
Rice PL; Peters SL; Beard KS; Ahnen DJ
Mol Cancer Ther; 2006 Mar; 5(3):746-54. PubMed ID: 16546990
[TBL] [Abstract][Full Text] [Related]
12. Sulindac sulfide-induced apoptosis involves death receptor 5 and the caspase 8-dependent pathway in human colon and prostate cancer cells.
Huang Y; He Q; Hillman MJ; Rong R; Sheikh MS
Cancer Res; 2001 Sep; 61(18):6918-24. PubMed ID: 11559570
[TBL] [Abstract][Full Text] [Related]
13. Disruption of cell adhesion and caspase-mediated proteolysis of beta- and gamma-catenins and APC protein in paclitaxel-induced apoptosis.
Ling Y; Zhong Y; Perez-Soler R
Mol Pharmacol; 2001 Mar; 59(3):593-603. PubMed ID: 11179455
[TBL] [Abstract][Full Text] [Related]
14. Nuclear beta-catenin displays GSK-3beta- and APC-independent proteasome sensitivity in melanoma cells.
Bonvini P; Hwang SG; El-Gamil M; Robbins P; Kim JS; Trepel J; Neckers L
Biochim Biophys Acta; 2000 Feb; 1495(3):308-18. PubMed ID: 10699468
[TBL] [Abstract][Full Text] [Related]
15. Butyrate-induced apoptotic cascade in colonic carcinoma cells: modulation of the beta-catenin-Tcf pathway and concordance with effects of sulindac and trichostatin A but not curcumin.
Bordonaro M; Mariadason JM; Aslam F; Heerdt BG; Augenlicht LH
Cell Growth Differ; 1999 Oct; 10(10):713-20. PubMed ID: 10547075
[TBL] [Abstract][Full Text] [Related]
16. Lactacystin augments the sulindac-induced apoptosis in HT-29 cells.
Choi HJ; Kim HH; Lee HS; Huh GY; Seo SY; Jeong JH; Kim JM; Yoo YH
Apoptosis; 2003 Jun; 8(3):301-5. PubMed ID: 12766490
[TBL] [Abstract][Full Text] [Related]
17. Sulindac sulfide-induced apoptosis is enhanced by a small-molecule Bcl-2 inhibitor and by TRAIL in human colon cancer cells overexpressing Bcl-2.
Sinicrope FA; Penington RC
Mol Cancer Ther; 2005 Oct; 4(10):1475-83. PubMed ID: 16227396
[TBL] [Abstract][Full Text] [Related]
18. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis.
Piazza GA; Rahm AL; Krutzsch M; Sperl G; Paranka NS; Gross PH; Brendel K; Burt RW; Alberts DS; Pamukcu R
Cancer Res; 1995 Jul; 55(14):3110-6. PubMed ID: 7606732
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells.
Zhang XM; Lin H; Chen C; Chen BD
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):127-33. PubMed ID: 10229667
[TBL] [Abstract][Full Text] [Related]
20. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells.
He Q; Luo X; Huang Y; Sheikh MS
Oncogene; 2002 Sep; 21(39):6032-40. PubMed ID: 12203115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
